【-】2025年全球健康进步指标2025.1_24页_2mb

2025 Indicators of Progress for Advancing Health Globally

Core Content

The 2025 Indicators of Progress for Advancing Health Globally report outlines seven key areas that will serve as markers to assess global health advancements. These indicators are designed to reflect measurable progress, even if they are proxies or indirect measures, and are intended to help stakeholders evaluate achievements and missed opportunities by the end of 2025. The report emphasizes the importance of addressing long-standing challenges, enhancing trust in healthcare and science, and leveraging new technologies like AI to transform global health outcomes.

Main Points and Key Indicators

1. Rebuilding Trust in Healthcare and Science

• Core Issue: Trust in healthcare professionals and scientific institutions has declined significantly, especially in the wake of the COVID-19 pandemic.
• Impact: Lower trust correlates with reduced vaccination rates and broader public health challenges.
• Indicator: Increase in the proportion of adults reporting "a lot" of trust in physicians and hospitals to at least 50%, up from 40% at the start of 2024.
• Additional Indicator: Public trust in science reverses the downward trend since 2019, with more than 60% of U.S. adults saying science has a "mostly positive" impact on society.
• Recommendation: Public health institutions must foster open dialogue, listen to diverse communities, and improve communication strategies to rebuild trust.

2. Advancing Universal Healthcare Coverage

• Core Issue: Universal Health Coverage (UHC) remains a critical goal under the UN's Sustainable Development Goals (SDGs).
• Current Status: The UHC Service Coverage Index has increased from 45/100 in 2000 to 68/100 in 2021, but progress has stalled in many regions.
• Indicator: The UHC Service Coverage Index rises above 75/100 in 2025.
• Recommendation: Sustained investment, recovery from the pandemic, and accelerating existing programs are essential to achieving UHC.

3. Closing the Primary Care Gap

• Core Issue: Primary care is a cornerstone of effective and equitable health systems, yet many countries, including high-income ones, face shortages and inefficiencies.
• Current Status: In the U.S., 28.7% of adults and 13.6% of children lacked a usual source of care in 2021.
• Indicator: Number of countries with established plans or reforms to expand primary care, including explicit workforce targets.
• Additional Indicator: Adoption of digital health strategies aimed at enhancing primary care delivery.
• Recommendation: Investment in technology and workforce expansion is critical to closing the primary care gap and improving health outcomes.

4. Progress on Addressing Long-Standing Healthcare Issues

• Core Issue: Persistent challenges like antimicrobial resistance (AMR) and pandemic preparedness require urgent and sustained action.
• Indicator: Passage of the PASTEUR Act by the U.S. Congress or similar legislation by the European Union.
• Additional Indicator: Final resolution of the Pandemic Preparedness Treaty by WHO member states.
• Recommendation: There is a need for legislative and policy changes to support the development of new antibiotics and global pandemic preparedness.

5. Delivering the Right Care for the Right Patient

• Core Issue: Non-communicable diseases (NCDs) such as hypertension place a growing burden on health systems.
• Indicator: Increase in per capita defined daily doses of antihypertensive medicines by 5% in 2025.
• Recommendation: Ensuring appropriate care delivery through better diagnostics and therapeutics is essential for improving global health outcomes.

6. Moving 'Upstream' with Disease Interception

• Core Issue: Most healthcare efforts are focused on treating diseases rather than preventing them.
• Trend: New approaches powered by AI are enabling researchers to move upstream and focus on disease interception.
• Indicator: Increase in the number of published papers on "disease interception" by 50% or more compared to 2024.
• Recommendation: Investing in AI-driven research can lead to early detection and prevention of diseases, reducing long-term healthcare burdens.

7. Advancing the Use of AI in Drug Development

• Core Issue: AI is transforming drug discovery and development, offering new opportunities to address unmet medical needs.
• Trend: AI-based investigational drugs are entering clinical trials, with the prospect of regulatory approval for fully AI-discovered drugs.
• Indicator: Increased activity in AI-driven drug development in 2025, particularly in addressing current unmet medical needs.
• Recommendation: Continued investment and innovation in AI technologies can lead to more effective and safer treatments for global populations.

Key Information

• The report highlights the importance of trust, universal coverage, primary care, long-standing issues, personalized care, disease interception, and AI in drug development as key areas for progress.
• It underscores the urgency of addressing these issues within a one-year timeframe, even though many long-term goals may take decades to achieve.
• The UHC Service Coverage Index and trust metrics are central to the report's evaluation framework.
• Digital health technologies and AI innovations are seen as enablers for improving efficiency and outcomes in healthcare.
• The PASTEUR Act and Pandemic Preparedness Treaty are highlighted as potential legislative milestones for 2025.

Conclusion

These seven indicators represent a strategic focus for global health stakeholders in 2025. They are designed to reflect progress in areas that are critical for long-term health improvement, while also addressing immediate challenges. The report serves as a call to action for governments, institutions, and the healthcare industry to prioritize these areas and ensure that measurable progress is made in the coming year.